Pierangelo Torquato

Pierangelo Torquato

Auto-generated profile, based on publicly available information

Pierangelo Torquato

Department of Pharmaceutical Sciences, University of Perugia, Italy

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PTPierangelo Torquato
Pierangelo Torquato
DGDanilo Giusepponi
Danilo Giusepponi
Anna AlisiAnna Alisi
Anna Alisi
RGRoberta Galarini
Roberta Galarini
DBDesirée Bartolini
Desirée Bartolini
FGFrancesco Galli
Francesco Galli
Two recent randomized controlled trials demonstrated improved radiographic, histological and hepatometabolic cues of non-alcoholic steatohepatitis (NASH) in pediatric patients treated with the ω-3 fatty acid docosahexaenoic acid (DHA) in combination with vitamin D (VD) or with choline (CHO) and vitamin E (VE), the DHA-VD and DHA-CHO-VE trials, respectively). In the present study we verified the nutritional compliance to these DHA-based multivitamin treatments; lipidomics biomarkers of the reported outcome on NASH indicators were also investigated. Samples were obtained from 30 biopsy-proven pediatric NASH patients of the DHA-CHO-VE trial randomized in multivitamin treatment group and placebo group (n = 15 each), and from 12 patients of the treatment group of the DHA-VD trial. All patients underwent 6-month therapy plus 6 months of follow-up. Plasma samples and clinical data were obtained at baseline and at the end of the study (12 months). Selected biomarkers included the free form of DHA and other ω-3 fatty acid arachidonic acid (AA), indices of the vitamin E status, and some hepatic metabolites of these lipids. Radiographic and histological improvements of treated patients were associated with increased concentrations of DHA, α-linolenic acid and α-tocopherol (i.e. VE), and with decreased AA that was also investigated in complex lipids by untargetd lipidomics. As a result a significantly lowered AA/DHA ratio was observed to represent the main indicator of the response to the DHA-based therapy. Furthermore, baseline levels of AA/DHA showed strong association with NAS and US improvement. A stable correction of DHA AA metabolism interaction is associated with the curative effect of this therapy and may represent a key nutritional endpoint in the clinical management of pediatric NASH.

1 December 2015 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
SCSilvia Ciffolilli
Silvia Ciffolilli
MWMaria Wallert
Maria Wallert
DBDesirée Bartolini
Desirée Bartolini
VKVerena Krauth
Verena Krauth
OWOliver Werz
Oliver Werz
FGFrancesco Galli
Francesco Galli

1 May 2016 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
PTPierangelo Torquato
Pierangelo Torquato
OROrsola Ripa
Orsola Ripa
DGDanilo Giusepponi
Danilo Giusepponi
RGRoberta Galarini
Roberta Galarini
DBDesirée Bartolini
Desirée Bartolini
FGFrancesco Galli
Francesco Galli

1 February 2019 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
PTPierangelo Torquato
Pierangelo Torquato
DBDesirée Bartolini
Desirée Bartolini
DGDanilo Giusepponi
Danilo Giusepponi
MPMarta Piroddi
Marta Piroddi
BSBartolomeo Sebastiani
Bartolomeo Sebastiani
FGFrancesco Galli
Francesco Galli

1 April 2017 in Toxicology in Vitro
Verified
Journal Article
Closed access
ARA. Russo
A. Russo
DBDesirée Bartolini
Desirée Bartolini
PTP. Torquato
P. Torquato
DGDanilo Giusepponi
Danilo Giusepponi
CBCarolina` Barola
Carolina` Barola
FGFrancesco Galli
Francesco Galli

1 November 2021 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
PTPierangelo Torquato
Pierangelo Torquato
DGDanilo Giusepponi
Danilo Giusepponi
DBDesirée Bartolini
Desirée Bartolini
CBCarolina` Barola
Carolina` Barola
RMRita Marinelli
Rita Marinelli
FGFrancesco Galli
Francesco Galli